Global Disease Control and Prevention Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Disease Control and Prevention Vaccine market report explains the definition, types, applications, major countries, and major players of the Disease Control and Prevention Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Astellas Pharma Inc

    • Serum Institute of India Pvt Ltd

    • GSK

    • Merck & Co Inc

    • Sanofi

    • Pfizer

    • Daiichi Sankyo

    • Sinovac Biotech Ltd

    • AstraZeneca PLC

    By Type:

    • Live-Attenuated

    • Inactivated

    • Recombinant Sub Unit and Toxoid

    By End-User:

    • Pediatric Vaccine

    • Adult Vaccine

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Disease Control and Prevention Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Disease Control and Prevention Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Disease Control and Prevention Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Disease Control and Prevention Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Disease Control and Prevention Vaccine Market- Recent Developments

    • 6.1 Disease Control and Prevention Vaccine Market News and Developments

    • 6.2 Disease Control and Prevention Vaccine Market Deals Landscape

    7 Disease Control and Prevention Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Disease Control and Prevention Vaccine Key Raw Materials

    • 7.2 Disease Control and Prevention Vaccine Price Trend of Key Raw Materials

    • 7.3 Disease Control and Prevention Vaccine Key Suppliers of Raw Materials

    • 7.4 Disease Control and Prevention Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Disease Control and Prevention Vaccine Cost Structure Analysis

      • 7.5.1 Disease Control and Prevention Vaccine Raw Materials Analysis

      • 7.5.2 Disease Control and Prevention Vaccine Labor Cost Analysis

      • 7.5.3 Disease Control and Prevention Vaccine Manufacturing Expenses Analysis

    8 Global Disease Control and Prevention Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Disease Control and Prevention Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Disease Control and Prevention Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Disease Control and Prevention Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Disease Control and Prevention Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Live-Attenuated Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Inactivated Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Sub Unit and Toxoid Consumption and Growth Rate (2017-2022)

    • 9.2 Global Disease Control and Prevention Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pediatric Vaccine Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult Vaccine Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Disease Control and Prevention Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.2 UK Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.5 France Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.3 India Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Disease Control and Prevention Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Disease Control and Prevention Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Disease Control and Prevention Vaccine Consumption (2017-2022)

    11 Global Disease Control and Prevention Vaccine Competitive Analysis

    • 11.1 Astellas Pharma Inc

      • 11.1.1 Astellas Pharma Inc Company Details

      • 11.1.2 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.1.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Serum Institute of India Pvt Ltd

      • 11.2.1 Serum Institute of India Pvt Ltd Company Details

      • 11.2.2 Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.2.4 Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 GSK

      • 11.3.1 GSK Company Details

      • 11.3.2 GSK Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 GSK Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.3.4 GSK Disease Control and Prevention Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck & Co Inc

      • 11.4.1 Merck & Co Inc Company Details

      • 11.4.2 Merck & Co Inc Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck & Co Inc Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.4.4 Merck & Co Inc Disease Control and Prevention Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Sanofi

      • 11.5.1 Sanofi Company Details

      • 11.5.2 Sanofi Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Sanofi Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.5.4 Sanofi Disease Control and Prevention Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Pfizer

      • 11.6.1 Pfizer Company Details

      • 11.6.2 Pfizer Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Pfizer Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.6.4 Pfizer Disease Control and Prevention Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Daiichi Sankyo

      • 11.7.1 Daiichi Sankyo Company Details

      • 11.7.2 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Daiichi Sankyo Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.7.4 Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Sinovac Biotech Ltd

      • 11.8.1 Sinovac Biotech Ltd Company Details

      • 11.8.2 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.8.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 AstraZeneca PLC

      • 11.9.1 AstraZeneca PLC Company Details

      • 11.9.2 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 AstraZeneca PLC Disease Control and Prevention Vaccine Main Business and Markets Served

      • 11.9.4 AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Disease Control and Prevention Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Live-Attenuated Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Inactivated Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Recombinant Sub Unit and Toxoid Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pediatric Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Disease Control and Prevention Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Disease Control and Prevention Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Disease Control and Prevention Vaccine

    • Figure of Disease Control and Prevention Vaccine Picture

    • Table Global Disease Control and Prevention Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Disease Control and Prevention Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Live-Attenuated Consumption and Growth Rate (2017-2022)

    • Figure Global Inactivated Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Sub Unit and Toxoid Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Table North America Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure United States Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure Germany Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure China Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Disease Control and Prevention Vaccine Consumption by Country (2017-2022)

    • Figure Australia Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Disease Control and Prevention Vaccine Consumption and Growth Rate (2017-2022)

    • Table Astellas Pharma Inc Company Details

    • Table Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Astellas Pharma Inc Disease Control and Prevention Vaccine Product Portfolio

    • Table Serum Institute of India Pvt Ltd Company Details

    • Table Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Serum Institute of India Pvt Ltd Disease Control and Prevention Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table GSK Disease Control and Prevention Vaccine Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Merck & Co Inc Disease Control and Prevention Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Sanofi Disease Control and Prevention Vaccine Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Pfizer Disease Control and Prevention Vaccine Product Portfolio

    • Table Daiichi Sankyo Company Details

    • Table Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Daiichi Sankyo Disease Control and Prevention Vaccine Product Portfolio

    • Table Sinovac Biotech Ltd Company Details

    • Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product Portfolio

    • Table AstraZeneca PLC Company Details

    • Table AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca PLC Disease Control and Prevention Vaccine Main Business and Markets Served

    • Table AstraZeneca PLC Disease Control and Prevention Vaccine Product Portfolio

    • Figure Global Live-Attenuated Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inactivated Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Sub Unit and Toxoid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Disease Control and Prevention Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Disease Control and Prevention Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.